TCR2 Therapeutics Inc. announced the appointment of Ian Somaiya as Chief Financial Officer. Mr. Somaiya brings to TCR2 more than 20 years of experience in finance and healthcare as a highly regarded equity research analyst on Wall Street. Prior to joining TCR2, Mr. Somaiya was Managing Director and Head of Biotechnology Research at BMO Capital Markets.